Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0GM9E
|
||||
| Former ID |
DIB014696
|
||||
| Drug Name |
RQ-00310941
|
||||
| Synonyms |
RQ-00202065; 5-HT 2b antagonists (oral, IBS), RaQualia; 5-HT 2b antagonists (oral, irritable bowel syndrome), RaQualia
|
||||
| Indication | Irritable bowel syndrome [ICD9: 564.1, 787.91; ICD10:A09, K58, K59.1] | Investigative | [543921] | ||
| Company |
RaQualia Pharma Inc
|
||||
| Canonical SMILES |
n1(nc(cc1c1cnc2c(c1)cccc2)C(=O)NCCN1CCOCC1)C
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 2B receptor | Target Info | Antagonist | [543921] | |
| PANTHER Pathway | 5HT2 type receptor mediated signaling pathway | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.